FR2882261B1 - USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES - Google Patents
USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETESInfo
- Publication number
- FR2882261B1 FR2882261B1 FR0501861A FR0501861A FR2882261B1 FR 2882261 B1 FR2882261 B1 FR 2882261B1 FR 0501861 A FR0501861 A FR 0501861A FR 0501861 A FR0501861 A FR 0501861A FR 2882261 B1 FR2882261 B1 FR 2882261B1
- Authority
- FR
- France
- Prior art keywords
- diabetes
- prevention
- preparation
- treatment
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Priority Applications (24)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0501861A FR2882261B1 (en) | 2005-02-21 | 2005-02-21 | USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES |
FR0504942A FR2882264A1 (en) | 2005-02-21 | 2005-05-12 | Use of rimonabant and N-peperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxamide, having cannabinoids receptor antagonistic activity, to treat and prevent type-II diabetes |
FR0505228A FR2882265B1 (en) | 2005-02-21 | 2005-05-23 | USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES. |
EP06709344A EP1853264A1 (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
PCT/FR2006/000376 WO2006087481A1 (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
AU2006215444A AU2006215444A1 (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
CA002597245A CA2597245A1 (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
CNA2006800052531A CN101119727A (en) | 2005-02-21 | 2006-02-20 | Use of cannabinoid receptor antagonists for the preparation of drugs in the treatment and prevention of type-2 diabetes |
ZA200707012A ZA200707012B (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
TW095105631A TW200640457A (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments useful in the prevention and treatment of type 2 diabetes |
BRPI0608183-5A BRPI0608183A2 (en) | 2005-02-21 | 2006-02-20 | use of rimonabant for the preparation of drugs useful in the prevention and treatment of type 2 diabetes |
EA200701781A EA011618B1 (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
KR1020077018993A KR20070104913A (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
MX2007009996A MX2007009996A (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes. |
UY29386A UY29386A1 (en) | 2005-02-21 | 2006-02-20 | USE OF RIMONABANT FOR THE PREPARATION OF USEFUL MEDICINES IN THE PREVENTION AND TREATMENT OF TYPE2 DIABETES. |
JP2007555669A JP2008530189A (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant to prepare a medicament that can be used in the prevention and treatment of type 2 diabetes |
ARP060100611A AR053812A1 (en) | 2005-02-21 | 2006-02-21 | USE OF RIMONABANT FOR THE PREPARATION OF USEFUL DRUGS IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES |
TNP2007000297A TNSN07297A1 (en) | 2005-02-21 | 2007-07-31 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
US11/832,865 US20080015229A1 (en) | 2005-02-21 | 2007-08-02 | Use of rimonabant for the preparation of medicaments useful in the prevention and treatment of type 2 diabetes |
CR9293A CR9293A (en) | 2005-02-21 | 2007-08-07 | USE OF RIMONABANT FOR THE PREPARATION OF USEFUL DRUGS IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES |
IL185401A IL185401A0 (en) | 2005-02-21 | 2007-08-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
MA30158A MA29262B1 (en) | 2005-02-21 | 2007-08-23 | USE OF RIMONABANT FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES |
NO20074767A NO20074767L (en) | 2005-02-21 | 2007-09-18 | Use of rimonabant for the preparation of drugs that can be used in the prevention and treatment of type 2 diabetes |
US12/402,988 US20090197917A1 (en) | 2005-02-21 | 2009-03-12 | Use of rimonabant for the preparation of medicaments useful in the prevention and treatment of type 2 diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0501861A FR2882261B1 (en) | 2005-02-21 | 2005-02-21 | USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2882261A1 FR2882261A1 (en) | 2006-08-25 |
FR2882261B1 true FR2882261B1 (en) | 2009-02-06 |
Family
ID=34954874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0501861A Expired - Fee Related FR2882261B1 (en) | 2005-02-21 | 2005-02-21 | USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101119727A (en) |
FR (1) | FR2882261B1 (en) |
ZA (1) | ZA200707012B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114452831B (en) * | 2022-01-24 | 2023-04-25 | 中南大学湘雅医院 | Surface-coated extracorporeal circulation modified membrane and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2789079B3 (en) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | PYRAZOLECARBOXYLIC ACID DERIVATIVE, ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
US20040122033A1 (en) * | 2002-12-10 | 2004-06-24 | Nargund Ravi P. | Combination therapy for the treatment of obesity |
-
2005
- 2005-02-21 FR FR0501861A patent/FR2882261B1/en not_active Expired - Fee Related
-
2006
- 2006-02-20 ZA ZA200707012A patent/ZA200707012B/en unknown
- 2006-02-20 CN CNA2006800052531A patent/CN101119727A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA200707012B (en) | 2008-12-31 |
FR2882261A1 (en) | 2006-08-25 |
CN101119727A (en) | 2008-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR20C1066I2 (en) | GDF TRAPS FOR USE IN THE TREATMENT OF ANEMIA | |
FR2867778B1 (en) | USE OF INDAZOLECARBOXAMIDE DERIVATIVES FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT AND PREVENTION OF MALARIA | |
IL236426B (en) | Use of a compound in combination with bortezomib in the preparation of a medicament for treating a neoplastic disease and pharmaceutical composition comprising a compound and bortezomib | |
GB0412753D0 (en) | Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis | |
NO20053920D0 (en) | Preparation and treatment of demyelination diseases and paralysis in the administration of remyelination agents. | |
FR2854074B1 (en) | USE OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS | |
FR2887450B1 (en) | CONCENTRATED INGREDIENT FOR THE TREATMENT AND / OR MODIFICATION OF SURFACES, AND ITS USE IN COSMETIC COMPOSITIONS | |
MA29084B1 (en) | INDENYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS | |
FR2900053B1 (en) | USE OF SAFRANAL, CROCINE, PICROCROCIN AND THEIR DERIVATIVES AS A SATITY AGENT FOR THE TREATMENT OF WEST OVERLOAD | |
MA28844B1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE AND ETHYNYLTRADIOL | |
FR2917622B1 (en) | USE OF A PAR1 ANTAGONIST IN THE TREATMENT OF ATRIAL FIBRILLATION. | |
FR2919187B1 (en) | USE OF YEAST SKIN FOR THE TREATMENT AND / OR PREVENTION OF HYPERINSULINEMIA. | |
DK1670482T4 (en) | USE OF CICLESONIDE IN THE TREATMENT OF RESPIRATORY DISEASES | |
FR2882261B1 (en) | USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES | |
FR2882263B1 (en) | USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF RENAL DISEASES | |
FR2882265B1 (en) | USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES. | |
FR2906469B1 (en) | USE OF COMPOUNDS OF THE AVERMECTIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS IN MAN | |
FR2861301B1 (en) | USE OF THE PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF METABOLIC SYNDROME. | |
FR2861300B1 (en) | USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF METABOLIC SYNDROME | |
FR2882262B1 (en) | USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF RENAL DISEASES | |
FR2894144B1 (en) | USE OF TYROSINE-ARGININE DIPEPTIDE IN A COSMETIC COMPOSITION OR FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
FR2906466B1 (en) | USE OF COMPOUNDS FROM THE MILBEMYCIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS IN MAN | |
FR2906467B1 (en) | USE OF COMPOUNDS FROM THE MILBEMYCIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS IN MAN | |
FR2892722B1 (en) | METHANONE-TYPE COMPOUNDS AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | |
FR2883180B1 (en) | USE OF ACETYL LEUCINE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF BALANCE DISORDERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20101029 |